VINC — Vincerx Pharma Cashflow Statement
0.000.00%
- $19.29m
- $14.18m
Annual cashflow statement for Vincerx Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0.001 | -0.12 | -39.3 | -65.4 | -40.2 |
Depreciation | |||||
Non-Cash Items | — | -0.054 | 0.27 | 6.73 | 3.84 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.001 | 0.008 | 5.61 | -1.02 | -4.19 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | 0 | -0.165 | -33.4 | -59.6 | -40.5 |
Capital Expenditures | — | — | -0.258 | 0 | — |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | -65.6 | -5 | -40.6 | 41.5 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | — | -65.6 | -5.26 | -40.6 | 41.5 |
Financing Cash Flow Items | 0 | 0.603 | — | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.025 | 66.5 | 88.5 | 0.28 | 0.114 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.025 | 0.66 | 49.8 | -99.8 | 1.12 |